Analyst Ratings for Milestone Pharmaceuticals (MIST)

MIST Rating Summary

MIST Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MIST
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $5.50 (+746.2%) * Over Last 12-Mos
Rating Score: 8.9 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/20/2026 Cantor Fitzgerald Olivia Brayer New Coverage Overweight
(N/A)
3.00
(N/A)
1.08
(0.65)
-39.81% Details
4/9/2026 Raymond James
» Updated 10/20/2026
Tiago Fauth New Coverage Strong Buy
(N/A)
5.00
(6.00)
1.78
(0.65)
-63.48% Details